227 related articles for article (PubMed ID: 26043337)
21. The heterogeneity of attenuated and brief limited psychotic symptoms: association of contents with age, sex, country, religion, comorbidities, and functioning.
Theisen C; Rosen M; Meisenzahl E; Koutsouleris N; Lichtenstein T; Ruhrmann S; Kambeitz J; Kambeitz-Ilankovic L; Riecher-Rössler A; Chisholm K; Upthegrove R; Antonucci LA; Bertolino A; Pigoni A; Salokangas RKR; Pantelis C; Wood SJ; Lencer R; Falkai P; Hietala J; Brambilla P; Schmidt A; Andreou C; Borgwardt S; Osman N; Schultze-Lutter F
Front Psychiatry; 2023; 14():1209485. PubMed ID: 37484669
[TBL] [Abstract][Full Text] [Related]
22. Age effects on basic symptoms in the community: A route to gain new insight into the neurodevelopment of psychosis?
Schultze-Lutter F; Ruhrmann S; Michel C; Kindler J; Schimmelmann BG; Schmidt SJ
Eur Arch Psychiatry Clin Neurosci; 2020 Apr; 270(3):311-324. PubMed ID: 30361925
[TBL] [Abstract][Full Text] [Related]
23. Sources of clinical distress in young people at ultra high risk of psychosis.
Rapado-Castro M; McGorry PD; Yung A; Calvo A; Nelson B
Schizophr Res; 2015 Jun; 165(1):15-21. PubMed ID: 25890793
[TBL] [Abstract][Full Text] [Related]
24. Abnormal involuntary movements are linked to psychosis-risk in children and adolescents: Results of a population-based study.
Kindler J; Schultze-Lutter F; Michel C; Martz-Irngartinger A; Linder C; Schmidt SJ; Stegmayer K; Schimmelmann BG; Walther S
Schizophr Res; 2016 Jul; 174(1-3):58-64. PubMed ID: 27160790
[TBL] [Abstract][Full Text] [Related]
25. Neural correlate of impulsivity in subjects at ultra-high risk for psychosis.
Lee TY; Kim SN; Jang JH; Shim G; Jung WH; Shin NY; Kwon JS
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():165-9. PubMed ID: 23603064
[TBL] [Abstract][Full Text] [Related]
26. No age effect in the prevalence and clinical significance of ultra-high risk symptoms and criteria for psychosis in 22q11 deletion syndrome: Confirmation of the genetically driven risk for psychosis?
Armando M; Schneider M; Pontillo M; Vicari S; Debbané M; Schultze-Lutter F; Eliez S
PLoS One; 2017; 12(4):e0174797. PubMed ID: 28406913
[TBL] [Abstract][Full Text] [Related]
27. The prognostic significance of attenuated psychotic symptoms in help-seeking youth.
Hazan H; Spelman T; Amminger GP; Hickie I; McGorry PD; Phillips LJ; Purcell R; Wood SJ; Yung AR; Nelson B
Schizophr Res; 2020 Jan; 215():277-283. PubMed ID: 31615738
[TBL] [Abstract][Full Text] [Related]
28. Bridging the phenomenological gap between predictive basic-symptoms and attenuated positive symptoms: a cross-sectional network analysis.
Müller H; Betz LT; Kambeitz J; Falkai P; Gaebel W; Heinz A; Hellmich M; Juckel G; Lambert M; Meyer-Lindenberg A; Schneider F; Wagner M; Zink M; Klosterkötter J; Bechdolf A
Schizophrenia (Heidelb); 2022 Aug; 8(1):68. PubMed ID: 36002447
[TBL] [Abstract][Full Text] [Related]
29. Adolescents at ultra-high risk of psychosis in Italian neuropsychiatry services: prevalence, psychopathology and transition rate.
Pelizza L; Azzali S; Garlassi S; Paterlini F; Scazza I; Chiri LR; Pupo S; Raballo A
Eur Child Adolesc Psychiatry; 2018 Jun; 27(6):725-737. PubMed ID: 29058115
[TBL] [Abstract][Full Text] [Related]
30. Cannabis-induced attenuated psychotic symptoms: implications for prognosis in young people at ultra-high risk for psychosis.
McHugh MJ; McGorry PD; Yung AR; Lin A; Wood SJ; Hartmann JA; Nelson B
Psychol Med; 2017 Mar; 47(4):616-626. PubMed ID: 27821204
[TBL] [Abstract][Full Text] [Related]
31. Adolescents at ultra-high risk for psychosis: long-term outcome of individuals who recover from their at-risk state.
de Wit S; Schothorst PF; Oranje B; Ziermans TB; Durston S; Kahn RS
Eur Neuropsychopharmacol; 2014 Jun; 24(6):865-73. PubMed ID: 24636460
[TBL] [Abstract][Full Text] [Related]
32. Ultra high risk status and transition to psychosis in 22q11.2 deletion syndrome.
Schneider M; Armando M; Pontillo M; Vicari S; Debbané M; Schultze-Lutter F; Eliez S
World Psychiatry; 2016 Oct; 15(3):259-265. PubMed ID: 27717277
[TBL] [Abstract][Full Text] [Related]
33. Frequency and correlates of DSM-5 attenuated psychosis syndrome in a sample of adolescent inpatients with nonpsychotic psychiatric disorders.
Gerstenberg M; Hauser M; Al-Jadiri A; Sheridan EM; Kishimoto T; Borenstein Y; Vernal DL; David L; Saito E; Landers SE; Carella M; Singh S; Carbon M; Jiménez-Fernández S; Birnbaum ML; Auther A; Carrión RE; Cornblatt BA; Kane JM; Walitza S; Correll CU
J Clin Psychiatry; 2015 Nov; 76(11):e1449-58. PubMed ID: 26646040
[TBL] [Abstract][Full Text] [Related]
34. Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis.
Rutigliano G; Valmaggia L; Landi P; Frascarelli M; Cappucciati M; Sear V; Rocchetti M; De Micheli A; Jones C; Palombini E; McGuire P; Fusar-Poli P
J Affect Disord; 2016 Oct; 203():101-110. PubMed ID: 27285723
[TBL] [Abstract][Full Text] [Related]
35. [Attenuated psychosis syndrome: A new diagnostic category for further study in DSM-5].
Samiotakis G; Kollias C; Lazaratou H; Anagnostopoulos D; Kontaxakis V
Psychiatriki; 2017; 28(2):120-130. PubMed ID: 28686559
[TBL] [Abstract][Full Text] [Related]
36. Relationship between duration of untreated prodromal symptoms and symptomatic and functional recovery.
Zhang T; Xu L; Tang Y; Cui H; Tang X; Wei Y; Wang Y; Hu Q; Qian Z; Liu X; Li C; Wang J
Eur Arch Psychiatry Clin Neurosci; 2019 Dec; 269(8):871-877. PubMed ID: 29942980
[TBL] [Abstract][Full Text] [Related]
37. Parsing neurobiological heterogeneity of the clinical high-risk state for psychosis: A pseudo-continuous arterial spin labelling study.
Oliver D; Davies C; Zelaya F; Selvaggi P; De Micheli A; Catalan A; Baldwin H; Arribas M; Modinos G; Crossley NA; Allen P; Egerton A; Jauhar S; Howes OD; McGuire P; Fusar-Poli P
Front Psychiatry; 2023; 14():1092213. PubMed ID: 36970257
[TBL] [Abstract][Full Text] [Related]
38. Checking the predictive accuracy of basic symptoms against ultra high-risk criteria and testing of a multivariable prediction model: Evidence from a prospective three-year observational study of persons at clinical high-risk for psychosis.
Hengartner MP; Heekeren K; Dvorsky D; Walitza S; Rössler W; Theodoridou A
Eur Psychiatry; 2017 Sep; 45():27-35. PubMed ID: 28728092
[TBL] [Abstract][Full Text] [Related]
39. Exploring the predictive power of the unspecific risk category of the Basel Screening Instrument for Psychosis.
Peralta D; Studerus E; Andreou C; Beck K; Ittig S; Leanza L; Egloff L; Riecher-Rössler A
Early Interv Psychiatry; 2019 Aug; 13(4):969-976. PubMed ID: 30019850
[TBL] [Abstract][Full Text] [Related]
40. Longitudinal Cognitive Changes in Young Individuals at Ultrahigh Risk for Psychosis.
Lam M; Lee J; Rapisarda A; See YM; Yang Z; Lee SA; Abdul-Rashid NA; Kraus M; Subramaniam M; Chong SA; Keefe RSE
JAMA Psychiatry; 2018 Sep; 75(9):929-939. PubMed ID: 30046827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
